Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH Basil C. Tarlatzis, Georg Griesinger, Arthur Leader, Luk Rombauts, Pieta C. IJzerman-Boon, Bernadette M.J.L. Mannaerts Reproductive BioMedicine Online Volume 24, Issue 4, Pages 410-419 (April 2012) DOI: 10.1016/j.rbmo.2012.01.005 Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or recombinant FSH (rFSH). Data from (A) Engage and Ensure (pooled) and (B) Trust. Reproductive BioMedicine Online 2012 24, 410-419DOI: (10.1016/j.rbmo.2012.01.005) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions
Figure 2 Receiver operating characteristic curve for logistic regression model. The area under the curve is 0.753, showing the sensitivity of the final logistic regression model. Reproductive BioMedicine Online 2012 24, 410-419DOI: (10.1016/j.rbmo.2012.01.005) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions